Results 201 to 210 of about 48,467 (263)

Reproductive outcomes in women with Hodgkin's lymphoma in a Danish fertility preservation cohort

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 8, Page 1587-1596, August 2026.
The risk of premature ovarian insufficiency increases with the intensity of alkylating chemotherapy. In general, fertility outcomes were favorable, but chances of live birth decreased with increased intensity of alkylating chemotherapy. Ovarian tissue transplantation enabled natural conception in women with premature ovarian insufficiency, supporting ...
Lotte Berdiin Colmorn, Elisabeth C. Larsen, Anette Tønnes Pedersen, Stine Gry Kristensen, Kirsten Tryde Macklon   +4 more
wiley   +1 more source

Patient-reported time toxicity with bispecific antibody therapies in relapsed/refractory follicular lymphoma and diffuse large B-cell lymphoma. [PDF]

Oncologist
Major A, Ma E, Masaquel A, Tsang M, Di M, Kaur S, Pophali P, Werner S, Bungay R, Latrémouille-Viau D, Guerin A, Reyes C, Wu M, Cassoli L, Torka P.   +14 more
europepmc   +1 more source

The management of follicular lymphoma

Annals of Oncology, 1991
openaire   +2 more sources

Evolving Pathology of Anaplastic Thyroid Carcinoma: Integrating Morphology, Immunohistochemistry, and Molecular Insights

Cancer Science, Volume 117, Issue 8, Page 2029-2039, August 2026.
Schematic overview of progression from differentiated thyroid carcinoma (DTC) to anaplastic thyroid carcinoma (ATC). ATC primarily develops via two pathways: the BRAF p.V600E‐mutated papillary thyroid carcinoma (PTC) pathway and the RAS‐mutated pathway. The origin and progression of BRAF/RAS‐wildtype ATC remain unclear.
Toru Odate, Tetsuo Kondo
wiley   +1 more source

Cardiogenic Shock and Symmetrical Peripheral Gangrene in Relapsed Follicular Lymphoma: A Case Report With Bordetella bronchiseptica Co-infection. [PDF]

Cureus
Thakkar K, Ismail B, Greene J.
europepmc   +1 more source

IgG4‐Related Disease Overlapping With Anti‐Acetylcholine Receptor Antibody–Positive Myasthenia Gravis

Clinical and Experimental Neuroimmunology, Volume 17, Issue 3, August 2026.
ABSTRACT Background IgG4‐related disease (IgG4‐RD) is a systemic, immune‐mediated, fibroinflammatory disorder with multiorgan involvement and variable clinical presentation, often creating diagnostic difficulty. Myasthenia gravis (MG) is an antibody‐mediated autoimmune disorder of the neuromuscular junction, most commonly associated with anti ...
Yumiko Yoshida, Ayami Okuzumi, Yuka Hosaka, Yuji Tomizawa, Taku Hatano   +4 more
wiley   +1 more source

Single-cell sequencing reveals dynamic immune features of paraneoplastic pemphigus in a patient with follicular lymphoma. [PDF]

Front Immunol
Wei R, Liu B, Liu Y, Li W, Chen Z, Lu J, Zheng Y, Yang S.   +7 more
europepmc   +1 more source

Population Pharmacokinetics of Rituximab in Treatment‐Naïve Chinese Patients With Diffuse Large B‐cell Lymphoma During Induction Therapy: Clinical Implications

Clinical and Translational Science, Volume 19, Issue 8, August 2026.
A schematic summary of the population pharmacokinetic model of rituximab in treatment‐naïve Chinese DLBCL patients during induction therapy, along with key clinical implications. ABSTRACT This study aimed to establish and validate a population pharmacokinetic model for rituximab during induction therapy in treatment‐naive patients with diffuse large B ...
Wan‐Yi Zhou, Jing Ling, Meng‐Meng Guan, Ying Qu, Ying‐Hui Dan, Rong Chen   +5 more
wiley   +1 more source

Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial.

JAMA Oncol
Shadman M, LeBlanc M, Rimsza L, Leonard JP, Smith SM, Li H, Friedberg JW.   +6 more
europepmc   +1 more source

Tafasitamab in relapsed follicular lymphoma: promise and remaining question. [PDF]

Ann Med Surg (Lond)
Irshad NU, Sheikh M, Riaz L, Sarfraz W, Imran SB.   +4 more
europepmc   +1 more source